The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

MLA

Enfermería, et al. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1430740945&authtype=sso&custid=ns315887.

APA

Enfermería, Fisiología, Biología celular e histología, Erizaintza, Fisiologia, Zelulen biologia eta histologia, Larrinaga Embeita, G., Valdivia Palacin, A., Arrieta Aguirre, I., Solano Iturri, J. D., Ugalde Olano, A., Loizaga Iriarte, A., Santos Martín, A., Pérez Fernández, A., Angulo, J. C., & López Fernández de Villaverde, J. I. (2024). The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy.

Chicago

Enfermería, Fisiología, Biología celular e histología, Erizaintza, Fisiologia, Zelulen biologia eta histologia, Gorka Larrinaga Embeita, et al. 2024. “The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1430740945&authtype=sso&custid=ns315887.